Effect of the combined extracts of Herba Epimedii and Fructus Ligustri Lucidi on sex hormone functional levels in osteoporosis rats

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Liu, Renhui ^a   Kang, Xue ^b   Xu, Liping ^a   Nian, Honglei ^a   Yang, Xinwei ^a   Shi, Haotian ^a   Wang, Xiujuan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Beijing Jishuitan Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; EPIMEDIUM EXTRACT; ESTRADIOL; ESTROGEN RECEPTOR; FOLLITROPIN; GONADORELIN; HORMONE RECEPTOR; LIGUSTRUM LUCIDUM EXTRACT; LUTEINIZING HORMONE; MESSENGER RNA; SEX HORMONE; TESTOSTERONE;

ALTERNATIVE MEDICINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEMUR; GENE EXPRESSION; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MALE; MORPHOMETRICS; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 84947648710     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/184802     Document Type: Article

References (40)

1. P. Gerdhem, "Osteoporosis and fragility fractures," Best Practice and Research: Clinical Rheumatology, vol. 27, no. 6, pp. 743-755, 2013.
2. X. Wang, L. Zhen, G. Zhang, M.-S.Wong, L. Qin, and X. Yao, "Osteogenic effects of flavonoid aglycones froman osteoprotective fraction of Drynaria fortunei-an in vitro efficacy study," Phytomedicine, vol. 18, no. 10, pp. 868-872, 2011.
3. T. Nakamura, T. Matsumoto, T. Sugimoto, and M. Shiraki, "Dose-response study of denosumab on bone mineral density and bone turnover markers in Japanese postmenopausal women with osteoporosis," Osteoporosis International, vol. 23, no. 3, pp. 1131-1140, 2012.
4. J.-Y. Reginster and N. Burlet, "Osteoporosis: a still increasing prevalence," Bone, vol. 38, supplement 1, no. 2, pp. 4-9, 2006.
5. N.O. Kuchuk,N.M.vanSchoor,S.M.F.Pluijm, J.H.Smit,W. de Ronde, and P. Lips, "The association of sex hormone levels with quantitative ultrasound, bone mineral density, bone turnover and osteoporotic fractures in older men and women," Clinical Endocrinology, vol. 67, no. 2, pp. 295-303, 2007.
6. H. D. Nelson, L. L. Humphrey, P. Nygren, S. M. Teutsch, and J. D. Allan, "Postmenopausal hormone replacement therapy: scientific review,"The Journal of theAmericanMedical Association, vol. 288, no. 7, pp. 872-881, 2002.
7. J. M. Kaufman, J. Y. Reginster, S. Boonen et al., "Treatment of osteoporosis in men," Bone, vol. 53, no. 1, pp. 134-144, 2013.
8. A. D. Pradhan, J. E. Manson, J. E. Rossouw et al., "Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the women's health initiative observational study," Journal of the American Medical Association, vol. 288, no. 8, pp. 980-987, 2002.
9. D. Pardini, "Hormone replacement therapy in menopause," Arquivos Brasileiros de Endocrinologia and Metabologia, vol. 58, no. 2, pp. 172-181, 2014.
10. X. Kang, Z. Li, W.-H. Zhang, Q. Zhou, R.-H. Liu, and X.-J. Wang, "Study on effect of combination of Epimedii Folium and Ligustri Lucidi Fructus on osteoporosis rats induced by retinoic acid," Zhongguo Zhongyao Zazhi, vol. 38, no. 23, pp. 4124-4128, 2013.
11. X. Kang, R.H. Liu,H. L.Nian et al., "Study on the effect of herba epimedii and fructus ligustri lucidi on osteoporosis model based on collagen type Imetabolism," Traditional Chinese Drug andClinical Pharmacology, vol. 25, no. 9, pp. 560-565, 2014.
12. Y.-K. Zhai, X. Guo, Y.-L. Pan et al., "A systematic review of the efficacy and pharmacological profile of herba epimedii in osteoporosis therapy," Pharmazie, vol. 68, no. 9, pp. 713-722, 2013.
13. H.-P. Ma, Z.-P. Jia, K.-M. Cheng, R.-X. Zhang, M.-X. Li, and J. Wang, "Effects of rat serum containing total flavonoid extract of Epimedium sagittatum on development of osteoblasts," Zhongguo Zhongyao Zazhi, vol. 33, no. 8, pp. 928-931, 2008.
14. D. Zhang, J. Zhang, C. Fong, X. Yao, and M. Yang, "Herba epimedii flavonoids suppress osteoclastic differentiation and bone resorption by inducing G2/M arrest and apoptosis," Biochimie, vol. 94, no. 12, pp. 2514-2522, 2012.
15. B.-L. Chen, D.-H. Xie, Z.-W. Wang, F.-B. Li, D.-L. Xu, and Y.-Q. Li, "Effect of total flavone of epimedium on expression of bone OPG, OPGL mRNA in ovariectomized rats," Zhong Guo Gu Shang, vol. 22, no. 4, pp. 271-273, 2009.
16. X. Feng, Y. Lyu, Z. Wu et al., "Fructus ligustri lucidi ethanol extract improves bone mineral density and properties through modulating calcium absorption-related gene expression in kidney and duodenum of growing rats," Calcified Tissue International, vol. 94, no. 4, pp. 433-441, 2014.
17. X.-L. Dong, M. Zhao, K.-K.Wong, C.-T. Che, andM.-S.Wong, "Improvement of calcium balance by Ligustri Lucidi Fructus extract in mature female rats was associated with the induction of serum parathyroid hormone levels," British Journal of Nutrition, vol. 108, no. 1, pp. 92-101, 2012.
18. X.-L. Dong, Y. Zhang, M. J. Favus, C.-T. Che, and M.-S.Wong, "Ethanol extract of Fructus Ligustri Lucidi increases circulating 1,25-dihydroxyvitamin D3 by inducing renal 25-hydroxyvitamin D-1 hydroxylase activity," Menopause, vol. 17,no. 6, pp. 1174-1181, 2010.
19. S. Johansson, P. M. Lind, H. Hakansson, H. Oxlund, J. Orberg, and H. Melhus, "Subclinical hypervitaminosis A causes fragile bones in rats," Bone, vol. 31, no. 6, pp. 685-689, 2002.
20. K. Michalsson, H. Lithell, B. Vessby, and H. Melhus, "Serum retinol levels and the risk of fracture,"The New England Journal of Medicine, vol. 348, no. 4, pp. 287-294, 2003.
21. H. Ma, M. H. Chung, Y. Lu, T. Nishihara, and M. Hattori, "Estrogenic effects of the herbal formula, menoprogen, in ovariectomized rats," Biological and Pharmaceutical Bulletin, vol. 33, no. 3, pp. 455-460, 2010.
22. K. D. R. Setchell and E. Lydeking-Olsen, "Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies," American Journal of Clinical Nutrition, vol. 78, no. 3, pp. 593S-609S, 2003.
23. P.-C. Leung andW.-S. Siu, "Herbal treatment for osteoporosis: a current review," Journal of TraditionalandComplementaryMedicine, vol. 3, no. 2, pp. 82-87, 2013.
24. R. H . Liu, X. Kang,W.H. Zhang et al., "Study of effects of combination of Epimedii Foliumi and Ligustri Lucidi Fructus on biochemical indicators in glucocorticoid-induced osteoporosis rats,"World ChineseMedicine, vol. 8, no. 12, pp. 1450-1453, 2013.
25. F. Deyhim, B. J. Stoecker, G. H. Brusewitz, L. Devareddy, and B. H. Arjmandi, "Dried plum reverses bone loss in an osteopenic rat model of osteoporosis," Menopause, vol. 12, no. 6, pp. 755-762, 2005.
26. A. M. Parfitt, M. K. Drezner, F. H. Glorieux et al., "Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee," Journal of Bone andMineral Research, vol. 2, no. 6, pp. 595-610, 1987.
27. R. H. Liu, J. Yang, P. Wang et al., "Study of the effects of combination of epimedii foliumi and ligustri lucidi fructus and dexamethasone onHPA axis and bonemetabolism of asthmatic model in rats," Chinese Journal of Experimental Traditional Medical Formulae, vol. 17, no. 5, pp. 155-157, 2011.
28. X. Kang, Q. Zhou, Z. Li et al., "Analysis of correlation of combination of Epimedii foliumi and Ligustri lucidi fructus on bone mineral density and hormone levels in glucocorticoid-induced osteoporosis rats," Chinese Journal of Experimental Traditional Medical Formulae, vol. 19, no. 23, pp. 276-279, 2013.
29. M. L. Bouxsein, "Mechanisms of osteoporosis therapy: a bone strength perspective," Clinical Cornerstone, vol. 5, no. 2, pp. S13-S21, 2003.
30. S. Majumdar, "A review of magnetic resonance (MR) imaging of trabecular bone micro-architecture: contribution to the prediction of biomechanical properties and fracture prevalence," Technology and Health Care, vol. 6, no. 5-6, pp. 321-327, 1998.
31. B. L. Riggs, S. Khosla, and L. J.Melton III, "A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men," Journal of Bone andMineral Research, vol. 13, no. 5, pp. 763-773, 1998.
32. S. Blouin,Y. Gallois, M. F.Moreau,M. F. Basl, andD.Chappard, "Disuse and orchidectomy have additional effects on bone loss in the aged male rat," Osteoporosis International, vol. 18, no. 1, pp. 85-92, 2007.
33. M. D'Amore, C. Bottalico, S. D'Amore, A. Di Chio, and P. Scagliusi, "Sex hormones andmale osteoporosis: a physiological outlook for prevention and therapy," Minerva Medica, vol. 91, no. 11-12, pp. 283-289, 2000.
34. P. Szulc, B. Claustrat, F.Marchand, and P.D.Delmas, "Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: the MINOS study," Journal of Clinical Endocrinology andMetabolism, vol. 88, no. 11, pp. 5240-5247, 2003.
35. K. M. Nicks, T. W. Fowler, and D. Gaddy, "Reproductive hormones and bone," Current Osteoporosis Reports, vol. 8, no. 2, pp. 60-67, 2010.
36. L. Sun, Y. Peng, A. C. Sharrow et al., "FSH directly regulates bone mass," Cell, vol. 125, no. 2, pp. 247-260, 2006.
37. M. F. R. Sowers, M. Jannausch, D. McConnell et al., "Hormone predictors of bone mineral density changes during the menopausal transition,"TheJournal ofClinical EndocrinologyandMetabolism, vol. 91, no. 4, pp. 1261-1267, 2006.
38. J. I.Aguirre, L. I. Plotkin,A. R.Gortazar et al., "A novel ligandindependent function of the estrogen receptor is essential for osteocyte and osteoblast mechanotransduction," The Journal of Biological Chemistry, vol. 282, no. 35, pp. 25501-25508, 2007.
39. H. Kawano, T. Sato, T. Yamada et al., "Suppressive function of androgen receptor in bone resorption," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 16, pp. 9416-9421, 2003.
40. M. Laurent, L. Antonio, M. Sinnesael et al., "Androgens and estrogens in skeletal sexual dimorphism," Asian Journal of Andrology, vol. 16, no. 2, pp. 213-222, 2014.